increase its rate and force of contraction; the opposite effects are noted in thyroid hormone deficiency. This has been considered to be an appropriate adjustment to the peripheral need for oxygen. Recent concept,1) however, is that the action of thyroid hormone is closely related to the effects of catecholamines, based on the fact that the cardiovascular effects in hyperthyroid patients are exaggerated to administration of catecholamines. No direct correlations between heart muscle catecholamines and thyroid hormone have been established, though a number of studies have been made on role of catecholamines in thyroid diseases. Serum cholinesterase activity has been found to be related to thyroid diseases,2)-4) but its significance has been poorly mentioned. Furthermore, this enzyme activity in heart muscle has never been studied in thyroid diseases.
From Medical Department of Prof. S. Yamagata, Tohoku University School of Medicine, Sendai. intraperitoneal administration of 30-40mg. of methylhexabital natrium, rats were placed inside of the apparatus with small packages of soda lime. Then the inside of apparatus is completely replaced by the oxygen and the slender glass tube is sealed by a few drops of water, which moves toward the inside with consumption of the oxygen to maintain the barometric equilibrium. The oxygen consumption was measured, as shown in Fig. 2 . The pulse rate measured through electrocardiogram is shown in Fig. 3 . After satisfactory hyper-and hypofunction of the thyroid gland was confirmed, rats were killed and hearts were removed for the following measurements. Catecholamines were eluated by the method of Euler and Orwen,5) using both ventricular muscle homogenized with a small amount of acid alcohol (pre- 
DISCUSSION
That effects of adrenaline to the cardiovascular system and on the oxygen consumption are similar to those of thyroid hormone is well known. It has been also found that the myocardial and vascular effects of catecholamines are greatly enhanced by thyroid hormone.11) Brewster and his associates12) have shown as a result of experiment in dogs that thyroxine per se has no effect either on the basal metabolic rate or on ventricular dynamics in the absence of the sympathetic nervous system and its pressor amines, and discussed that the signs and symptoms of hyperthyroidism might be interpreted as a result of increased catecholamine activities caused by thyroxine. Murray and Kelly13) found that response to adrenaline in thyroid patients was of diagnostic value as well as the basal metabolic rate, protein bound iodine or I131 uptake. Although there have been convincing facts that the cardiovascular system is more sensitive to catecholamines in hyperthyroid patients than in normal individuals, the mechanism has been incompletely understood. Several hypotheses have been proposed: (1) increased catecholamines in the blood, (2) decreased monoamine oxidase activity, and (3) decreased contents of catecholamines in organs. As to the first hypothesis, Diller and Kilpatrik14) reported that the excretion of adrenaline in hyperthyroid patients was increased in parallel with its severity using biological assay technique. Goldfien and co-workers15) found an increased adrenaline in plasma in hyperthyroid patients measuring the ethylenediamine condensation method. Euler,16) however, states that any definite relationships between catecholamine excretion and thyroid diseases were found. Ishida17) recently published his work on the metabolism of catecholamines in thyroid patients and reported that no any distinct changes in the urinary excretion of catecholamines and their metabolites were found in thyroid patients. The main metabolic pathway of catecholamine, as generally accepted, is catecholamine-methoxy catecholamine (or dihydroxy mandelic acid)-vanil mandelic acid. So if there is an increased endogenous production of catecholamines in a certain pathological condition, an increased urinary excretion of catecholamines, methoxy catecholamine and vanil mandelic acid should occur. Then Ishida concludes that the endogenous production of catecholamines is in the normal range in hyperthyroid patients.
As to the second hypothesis, Spinks18) has found a decreased monoamine oxidase activity in the wall of the aorta in rabbits by administration of thyroxine. Burn19) supported this hypothesis with many experiments.
Furthermore, Spinks and Burn,20) Trendelenburg,21) and Zile and Lardy22) found a decreased monoamine oxidase activity in the homogenate of liver in rats or rabbits administered pulverized thyroid gland. They reported that a monoamine oxidase activity is increased in the liver homogenate of thyroidectomized rats. If there are alterations in these catecholamine inactivating enzymes in thyroid diseases, the metabolism of catecholamines should be modified. Ishida has shown that urinary excretion of the metabolites of catecholamines or their ratio (urinary catecholamines/methoxy catecholamines/vanil mandelic acid) are ranging from 1/11/120 to 1/16/44 in normal subjects as well as hyperthyroid patients before and after administration of monoamine oxidase inhibitors. He also states that there are no differences in that ratio in 2-24 hour urine specimens after infusion of noradrenaline between hyperthyroid patients and controls. He concluded that activities of monoamine oxidase and O-methyl transferase are normal in thyroid diseases. But there is still a possibility, proposed by Burn in the explaining the increased sensitivity to catecholamines in hyperthyroid animals, that the enzyme activity is altered only in the vascular wall leaving the other tissues intact.
As to the third hypothesis, Burn23) has proposed his concept that response of an organ to adrenaline or noradrenaline is increased with the decrease in the content of catecholamine in that organ. He deduced this conclusion from the observation that the spiral strips of rabbit's aorta, in which the tissue catecholamine was previously deplected by reserpine, responded more vigorously than untreated controls. There, the exaggerated sensitivity in hyperthyroidism can be easily explained if the catecholamine content in the cardiovascular system is decreased.
In summary, the patterns of urinary excretion of catecholamines and their metabolites are unchanged in hyperthyroid patients and the circulating catecholamines in the blood are presumably in the normal limits. The enzyme system involved in the metabolism of catecholamines is perfectly normal in hyperthyroid patients. Increased responsiveness of organs to catecholamines has been suggested to be most likely.
Our study showed very significant decrease of adrenaline content in the heart muscle of hyperthyroid rats. This appears to prove Burn's concept is correct. Then it is considered that various cardiovascular signs and symptoms in hyperthyroidism are due to relative hyperadrenalemia based upon the decrease of adrenaline content in the heart muscle. Further elucidation, however, is necessary to find in what process the decrease of adrenaline content in the heart muscle occurs. Noradrenaline content in the heart muscle was unchanged in hyperthyroid group. It is unknown why only adrenaline content is decreased and noradrenaline content is unchanged, although a decrease of noradrenaline content is seemingly to occur. Then possibilities may be proposed that N-methylation process of noradrenaline to adrenaline is blocked in the heart muscle or an uptake of adrenaline into the muscle is blocked in hyperthyroidism. diseases, though numerous studies have been performed on many enzyme systems. Significant decrease of glutamic oxaloacetic transaminase and glutamic pyruvic transaminase activities in the heart muscle in hyperthyroid as well as hypothyroid rats are interesting informations, which appear in the literature for the first time. Muscular thinning or swelling is a known finding in thyroid diseases. As shown in Fig. 8 and 9 , electron microscopic specimens of heart muscle were also made in this study. Although no remarkable destruction in the fine structure of muscle was noted, the muscular involvement is significant enough to make glutamic oxaloacetic transaminase and glutamic pyruvic transaminase liberated into the blood, which has not been confirmed, however.
This will be evaluated in the near future.
SUMMARY
(1) Heart muscle catecholamine content, pseudocholinesterase activity, and glutamic oxaloacetic transaminase and glutamic pyruvic transaminase activities were measured in rats after administration of 3, 5, 3' triiodothyronine and 1-methy 1-2-mercaptoimidazole in order to find further correlations between these and the effects of thyroid hormones. Heart muscle adrenaline content significantly decreased in hyperthyroid group compared with hypothyroid and coutrol group. The significance of this finding in explaining hypersensitivity of adrenaline in hyperthyroidism was discussed. The metabolism of catecholamines in relation to this finding was also discussed.
(2) Pseudocholinesterase activity in the heart muscle significantly increased in hyperthyroid group and decreased in hypothyroid group compared with control group. Its possible significance in thyroid diseases was discussed.
(3) Glutamic oxaloacetic transaminase and glutamic pyruvic transaminase activities in the heart muscle significantly decreased in hyperthyroid as well as hypothyroid group compared with control group. It is likely that muscular involvements in thyroid diseases are significant enough to cause possible liberation of these enzymes.
